Posts

How to Decide if a Job Offer is Worth Taking

Image
  Turning down a job offer after a long and involved interview process within the pharma and life sciences sector is a difficult decision to make, but it pays not to be hasty when you are deciding where to spend 40 hours a week of your time.   It is important to find the right fit for you, and it pays to take time to evaluate a job offer before deciding to accept or reject it. You deserve to work in a role that excites you and allows you to have an acceptable work/life balance. While you may be initially excited by a large salary package, it is important to choose a role that will tick boxes beyond the number at the end of your monthly paycheck.    This article lists the top aspects to consider when you are considering a job offer to help you make the right decision when advancing your career in pharmaceuticals and life sciences.

EPM Scientific Salary Review 2021 | Asia Pacific

Image
  ​ ​We are kicking off our inaugural  Life Sciences Salary Review of 2021 . Take the Survey today! ​ EPM Scientific is kicking off its first annual    Life Sciences Salary Snapshot  !  Make sure you don’t miss the opportunity to participate in the comprehensive survey and contribute to our statistical research on the latest salary trends characterising the industry. Salary benchmarks offer a future-facing perspective into the current state of the industry. By completing the survey, not only does it set a cornerstone for the right optimal salaries, but it can help you reach a desired career goal, so you can continue to make a full contribution to the sector. The questions in our survey cover a myriad of topics on salary and benefits, work-life balance, and remuneration packages. This survey aims to shine an illuminating light on the packages given to employees within the different Life Sciences sectors. Whether you work R&D, Clinical Development, C...

The Growing Importance of Quality in the Medical Device Industry

Image
  When it comes to medical devices, what's the cost of quality? It could be as much as $36 billion, according to research by McKinsey & Company which suggests the total direct cost of quality is between 6.8% and 9.4% of industry sales. [1]   That’s equivalent to between $26 billion and $36 billion each year. One-third of that amount is ensuring good quality, the remaining two-thirds is the direct cost of poor quality. Global sales of medical devices reached $380 billion last year, rising from $260 billion in 2006 [1]   – but during that time, the quality of these devices failed to keep pace.   The industry has realized it needs to do more to capture the value of good quality in medical devices. The growth in demand for medical devices The medical device industry is worth $140 billion in the US, making it the largest medical device consumer in the world. [2]   The industry encompasses more than 5,800 companies in the US alone (80% of which employ fewer than 5...

Reimagine the Future Through Talent

Image
  With a rapidly evolving business climate on the horizon, how can firms be agile, innovative, and sharpen their operational capabilities to remain at the competitive edge of Life Sciences? It begins by  reimagining the future through talent.   By placing talent at the heart of business decisions and growth strategies, Life Sciences players can better prepare for tomorrow’s challenges and change the dial of their success.    The definitive guide:  ‘ Reimagine the Future Through Talent ’  gives a glimpse into the current state of the Asian Pacific Life Sciences market and provides a framework for crafting a talent-driven corporation.

New to the Market: Phaidon International Launches Dedicated Regulatory and Legal Talent Partner, Larson Maddox 

  EPM Scientific’s parent company,   Phaidon International , has recently revealed the launch of Larson Maddox – a specialist subsidiary talent partner for the Regulatory and Legal market.  Adding to the group portfolio, Larson Maddox sharpens the award-winning firm’s service offering and provides a platform for exponential growth.  Phaidon International Group COO,  Steve Yendell , comments, “In response to consistent demand from our client partners and candidate network, we are launching Larson Maddox to focus exclusively on the regulatory and legal talent challenges across a broad range of sectors.” He continues, “Larson Maddox complements our existing specialist brand portfolio perfectly by enabling us to help clients from all sectors secure talent to navigate the rapidly evolving Regulatory and Legal landscape.”   For Phaidon International, the creation of a dedicated brand is imperative to support their clients whose rapid growth in key industry verticals must be met...